164 related articles for article (PubMed ID: 24835144)
1. Seasonality pattern of breast, colorectal, and prostate cancer is dependent on latitude.
Ho A; Gabriel A; Bhatnagar A; Etienne D; Loukas M
Med Sci Monit; 2014 May; 20():818-24. PubMed ID: 24835144
[TBL] [Abstract][Full Text] [Related]
2. Racial/ethnic disparities in de novo metastases sites and survival outcomes for patients with primary breast, colorectal, and prostate cancer.
Akinyemiju T; Sakhuja S; Waterbor J; Pisu M; Altekruse SF
Cancer Med; 2018 Apr; 7(4):1183-1193. PubMed ID: 29479835
[TBL] [Abstract][Full Text] [Related]
3. Seasonal and geographical variations in lung cancer prognosis in Norway. Does Vitamin D from the sun play a role?
Porojnicu AC; Robsahm TE; Dahlback A; Berg JP; Christiani D; Bruland OS; Moan J
Lung Cancer; 2007 Mar; 55(3):263-70. PubMed ID: 17207891
[TBL] [Abstract][Full Text] [Related]
4. Infective endocarditis and cancer in the elderly.
García-Albéniz X; Hsu J; Lipsitch M; Logan RW; Hernández-Díaz S; Hernán MA
Eur J Epidemiol; 2016 Jan; 31(1):41-9. PubMed ID: 26683995
[TBL] [Abstract][Full Text] [Related]
5. Risk of Breast, Prostate, and Colorectal Cancer Diagnoses Among HIV-Infected Individuals in the United States.
Coghill AE; Engels EA; Schymura MJ; Mahale P; Shiels MS
J Natl Cancer Inst; 2018 Sep; 110(9):959-966. PubMed ID: 29529223
[TBL] [Abstract][Full Text] [Related]
6. Season of diagnosis and prognosis in breast and prostate cancer.
Holmberg L; Adolfsson J; Mucci L; Garmo H; Adami HO; Möller H; Johansson JE; Stampfer M
Cancer Causes Control; 2009 Jul; 20(5):663-70. PubMed ID: 19067189
[TBL] [Abstract][Full Text] [Related]
7. The association of ultraviolet radiation-B (305 nm), season of diagnosis, and latitude on the survival outcome of prostate cancer in the high UV environment of Australia.
Nair-Shalliker V; Smith DP; Egger S; Clements MS; Rahman MB; Armstrong BK
Cancer Causes Control; 2013 Nov; 24(11):2005-11. PubMed ID: 23974842
[TBL] [Abstract][Full Text] [Related]
8. Measuring breast, colorectal, and prostate cancer screening with medicare claims data.
Freeman JL; Klabunde CN; Schussler N; Warren JL; Virnig BA; Cooper GS
Med Care; 2002 Aug; 40(8 Suppl):IV-36-42. PubMed ID: 12187166
[TBL] [Abstract][Full Text] [Related]
9. Circulating 25-Hydroxyvitamin D Concentration and Risk of Breast, Prostate, and Colorectal Cancers: The Melbourne Collaborative Cohort Study.
Heath AK; Hodge AM; Ebeling PR; Eyles DW; Kvaskoff D; Buchanan DD; Giles GG; Williamson EJ; English DR
Cancer Epidemiol Biomarkers Prev; 2019 May; 28(5):900-908. PubMed ID: 30842127
[TBL] [Abstract][Full Text] [Related]
10. Long-term health outcomes in a British cohort of breast, colorectal and prostate cancer survivors: a database study.
Khan NF; Mant D; Carpenter L; Forman D; Rose PW
Br J Cancer; 2011 Nov; 105 Suppl 1(Suppl 1):S29-37. PubMed ID: 22048030
[TBL] [Abstract][Full Text] [Related]
11. The Use of Telmisartan and the Incidence of Cancer.
Tascilar K; Azoulay L; Dell'Aniello S; Bartels DB; Suissa S
Am J Hypertens; 2016 Dec; 29(12):1358-1365. PubMed ID: 27557862
[TBL] [Abstract][Full Text] [Related]
12. Disenrollment from Medicare managed care among beneficiaries with and without a cancer diagnosis.
Elkin EB; Ishill N; Riley GF; Bach PB; Gonen M; Begg CB; Schrag D
J Natl Cancer Inst; 2008 Jul; 100(14):1013-21. PubMed ID: 18612131
[TBL] [Abstract][Full Text] [Related]
13. Racial Disparities Vary by Patient Life Expectancy in Screening for Breast, Prostate, and Colorectal Cancers.
Schoenborn NL; Huang J; Boyd CM; Pollack CE
J Gen Intern Med; 2020 Nov; 35(11):3389-3391. PubMed ID: 31797159
[No Abstract] [Full Text] [Related]
14. Annual Report to the Nation on the status of cancer, 1975-2010, featuring prevalence of comorbidity and impact on survival among persons with lung, colorectal, breast, or prostate cancer.
Edwards BK; Noone AM; Mariotto AB; Simard EP; Boscoe FP; Henley SJ; Jemal A; Cho H; Anderson RN; Kohler BA; Eheman CR; Ward EM
Cancer; 2014 May; 120(9):1290-314. PubMed ID: 24343171
[TBL] [Abstract][Full Text] [Related]
15. Pre- and Post-diagnosis Diabetes as a Risk Factor for All-Cause and Cancer-Specific Mortality in Breast, Prostate, and Colorectal Cancer Survivors: a Prospective Cohort Study.
Tao H; O'Neil A; Choi Y; Wang W; Wang J; Wang Y; Jia Y; Chen X
Front Endocrinol (Lausanne); 2020; 11():60. PubMed ID: 32132977
[No Abstract] [Full Text] [Related]
16. The association between Medicare accountable care organization enrollment and breast, colorectal, and prostate cancer screening.
Resnick MJ; Graves AJ; Gambrel RJ; Thapa S; Buntin MB; Penson DF
Cancer; 2018 Nov; 124(22):4366-4373. PubMed ID: 30412287
[TBL] [Abstract][Full Text] [Related]
17. Lower TSH and higher free thyroxine predict incidence of prostate but not breast, colorectal or lung cancer.
Chan YX; Knuiman MW; Divitini ML; Brown SJ; Walsh J; Yeap BB
Eur J Endocrinol; 2017 Oct; 177(4):297-308. PubMed ID: 28684452
[TBL] [Abstract][Full Text] [Related]
18. Clopidogrel use and cancer-specific mortality: a population-based cohort study of colorectal, breast and prostate cancer patients.
Hicks BM; Murray LJ; Hughes C; Cardwell CR
Pharmacoepidemiol Drug Saf; 2015 Aug; 24(8):830-40. PubMed ID: 26017274
[TBL] [Abstract][Full Text] [Related]
19. Hodgkin Lymphoma has a seasonal pattern of incidence and mortality that depends on latitude.
Borchmann S; Müller H; Engert A
Sci Rep; 2017 Nov; 7(1):14903. PubMed ID: 29097683
[TBL] [Abstract][Full Text] [Related]
20. Survival patterns for the top four cancers in Canada: the effects of age, region and period.
Ugnat AM; Xie L; Semenciw R; Waters C; Mao Y
Eur J Cancer Prev; 2005 Apr; 14(2):91-100. PubMed ID: 15785312
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
